Mayflower Biosciences offers an extensive collection of biochemicals that act on transcription factors for both research and drug discovery programs. For bulk qualities, contact us at sales@mayflowerbio.com for a no-obligation quote.
Compound (primary activity*)
* listed compounds act on transcription factors, even though the primary activity may highlight a different target class. See the individual product page for more detail or contact us at sales@mayflowerbio.com for product documentation.
|
10058-F4 (Myc inhibitor) 10074-G5 (c-Myc inhibitor) 24(S)-Hydroxycholesterol (Endogenous cholesterol metabolite) 24,25-Epoxycholesterol (LXR agonist) 25-Hydroxycholesterol (Biologically active cholesterol metabolite) 27-Hydroxycholesterol (Cholesterol metabolite) 4μ8C (IRE1 ribonuclease inhibitor) 5a,6a-Epoxycholesterol (LXR ligand) 6-Formylindolo(3,2-b)carbazole (AHR endogenous agonist) Adapalene (Retinoid RARβ/γ agonist) AI-1 (Nrf2 activator) AM-580 (RARα agonist) AR7 (Activates chaperone mediated autophagy) AS1842856 (FOXO1 inhibitor) BADGE (PPARγ antagonist) BAY 87-2243 (HIF-1 / Mitochondrial complex I inhibitor) Bexarotene (Retinoid RXR agonist) BI-6015 (HNF4α inhibitor) BIBR1532 (Telomerase inhibitor) BMH-21 (RNA polymerase I inhibitor) Caerulomycin A (Blocks STAT1 signaling / Immunosuppressant) Cafestol (Neuroprotective) CB-103 (Notch signaling pathway inhibitor) CBL0137 (FACT histone chaperone inhibitor) CCT251236 (HSF stress pathway inhibitor) CDDO-Me (Nrf2 activator) C-DIM 12 (Nurr1 activator; NFκB inhibitor) C-DIM 8 (Nur77 antagonist) Ceapin-A7 (ATF6a/UPR inhibitor) CH-223191 (Arylhydrocarbon receptor antagonist) Ciglitazone (PPARγ agonist) Cinnabarinic Acid (AhR ligand (endogenous)) Compound 147 (ER stress sensing protein ATF6 activator) Dexamethasone (Apoptosis inducing glucocorticoid) DiMNF (AhR modulator (SAhRM)) DPN (Estrogen ERβ agonist) DY131 (Estrogen-related receptor ERRβ and ERRγ agonist) Echinomycin (HIF1α inhibitor) Elafibranor (PPARα/δ agonist) Eltrombopag (Thrombopoietin agonist) Enzalutamide (Non-steroidal antiandrogen) ERGi-USU (ERG inhibitor) Fatostatin (SREBP activation inhibitor) FH-535 (Wnt/β-cantenin inhibitor) Formononetin (PPARg activator; increases adipocyte thermogenesis) FQI1 (LSF inhibitor) Fulvestrant (Estrogen receptor antagonist) GSK-3787 (PPARδ antagonist) GSK4112 (Rev-Erbα agonist) Guggulsterone-(Z) (FXR antagonist) GW-501516 (PPARδ agonist) GW-9662 (PPARγ antagonist) HIF-2α-I2 (HIF-2α antagonist) Honokiol (SIRT3 activator) ICG-001 (Wnt/β-catenin inhibitor) iCRT5 (β-catenin inhibitor) |
IMR-1 (Notch transcriptional activation inhibitor) Isohelenin (NFkB inhibitor ) ISX9 (Neurogenic differentiation inducer) IWP-4 (Porcn inhibitor: Wnt/Beta-catenin pathway inhibitor) KC7F2 (HIF-1α inhibitor) KY-02111 (Wnt pathway inhibitor) Kynurenine (L) (Endogenous Ahr agonist) Laquinimod (Immunomodulator) Methoprene Acid (RXR agonist) Mifepristone (RU486) (Glucocorticoid antagonist) MRL-24 (PPARγ partial agonist) Napabucasin (STAT3 inhibitor / Cancer cell stemness inhibitor) Niclosamide (STAT3 signaling inhibitor) NSC59984 (p53 activator) NSC66811 (p53/mdm2 inhibitor) Nutlin-3 (p53/mdm2 inhibitor) Obeticholic acid (FXR agonist) Oltipraz (Nrf2 activator) Pifithrin α (p53 inhibitor) Pioglitazone HCl (PPARγ agonist) PNU 74654 (Wnt pathway blocker) PRIMA-1MET (Reactivates mutant p53) PTC-209 (BMI-1 inhibitor) Retinoic acid (Retinoid RAR agonist) RITA (p53 activator) Ro 415253 (RARα antagonist) Rosiglitazone Maleate (PPARγ agonist) SI-2 (Potent inhibitor of steroid receptor coactivator-3 (SRC-3)) SKL2001 (Wnt/ß-Catenin pathway activator) SL-01 (p53/mdm2 inhibitor) SLU-PP-332 (pan-ERR agonist/Exercise mimetic) SP100030 (Dual NF-kB / AP-1 inhibitor) SR0987 (RORγt agonist) SR1 (Maintains stem cells in pluripotent state) SR-1001 (RORag inverse agonist) SR1078 (ROR agonist) SR3335 (RORα partial inverse agonist) SR-8278 (REV-ERBα agonist) SR-9009 (RevErbα/β agonist) SR9243 (LXR inverse agonist) Stattic (STAT3 inhibitor) Stauprimide (Primes stem cells for differentiation) T0901317 (LXR agonist) Tamoxifen citrate (ER antagonist; GPR30 agonist) Tanshinone IIA (AP-1 transcription factor inhibitor) TCPOBOP (CAR agonist) TPCA-1 (Selective inhibitor of IκB kinase 2 (IKK2)) Triptolide (Immunosupressant) Troglitazone (PPARγ agonist) TTNPB (Retinoic RAR agonist) Verrucarin A (Steroid receptor coactivator-3 inhibitor) Verteporfin (YAP inhibitor) WP1066 (JAK/STAT3 inhibitor) WS6 (Stimulates pancreatic beta-cell proliferation) WY-14643 (PPARα agonist) |